Agilent Expands SureGuide Portfolio with CRISPR-based Products to Accelerate Disease Research – Business Wire (press release)
|
Agilent Expands SureGuide Portfolio with CRISPR-based Products to Accelerate Disease Research
Business Wire (press release) SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) today announced the first expansion of the SureGuide pooled CRISPR libraries for functional genomics, offering pooled libraries for CRISPR activation and interference (CRISPR … |
